Sunday, 22 November 2026 Every SEC filing alert, by company
ALFAFINDER USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Mosaic ImmunoEngineering Q3 2026 Results: Net Loss of $166K, Loss Widens

Mosaic ImmunoEngineering Inc. reported a net loss of $518,741 for the nine months ended September 30, 2026, with cash reserves dwindling to just $151. The company issued a going concern warning, stating that current capital is insufficient to fund operations for the next twelve months without additional financing.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Profit before tax-0.2-0.2
Net income-0.2-0.2
EPS (diluted, $ a share)$-0.02$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: CPMV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Mosaic ImmunoEngineering Inc.: key numbers

Share price
$0.0850Close, Nov 20
Market cap
$616K
Shares outstanding
7.24MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFAFINDER USA alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.